The majority of these techniques were created using clinical and pathological characteristics, including pre-operative serum prostate-specific antigen (PSA), tumor stage, Gleason score, extracapsular extension (ECE), surgical margin (SM), and seminal vesicle involvement(SV) [5–8]. The gene discussed is KLK3; the disease is neoplasm.